Dr. Daniel Young, MD

Internal Medicine Bentonville, AR Male
NPI: 1265656425
Total Payments
$41,853
2024 Payments
$20,335
Companies
23
Transactions
549
Medicare Patients
2,740
Medicare Billing
$483,231

Payment Breakdown by Category

Other$27,440 (65.6%)
Food & Beverage$10,094 (24.1%)
Travel$3,936 (9.4%)
Education$383.37 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $27,440 12 65.6%
Food and Beverage $10,094 518 24.1%
Travel and Lodging $3,936 13 9.4%
Education $383.37 6 0.9%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $34,176 131 $0 (2024)
ViiV Healthcare Company $1,784 106 $0 (2024)
Insmed, Inc. $1,203 55 $0 (2024)
Merck Sharp & Dohme LLC $984.88 66 $0 (2024)
ABBVIE INC. $888.36 59 $0 (2024)
Cumberland Pharmaceuticals, Inc. $738.69 19 $0 (2022)
Astellas Pharma US Inc $513.03 16 $0 (2024)
Allergan, Inc. $496.45 32 $0 (2020)
La Jolla Pharmaceutical Company $312.78 20 $0 (2023)
Paratek Pharmaceuticals, Inc. $148.25 8 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $20,335 88 Gilead Sciences, Inc. ($19,373)
2023 $14,919 96 Gilead Sciences, Inc. ($13,765)
2022 $1,867 84 Cumberland Pharmaceuticals, Inc. ($562.03)
2021 $1,276 72 ViiV Healthcare Company ($355.79)
2020 $877.61 51 ViiV Healthcare Company ($296.53)
2019 $1,372 86 ViiV Healthcare Company ($296.16)
2018 $1,023 60 Astellas Pharma US Inc ($254.17)
2017 $183.22 12 ViiV Healthcare Company ($54.93)

All Payment Transactions

549 individual payment records from CMS Open Payments — Page 1 of 22

Date Company Product Nature Form Amount Type
12/20/2024 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $22.25 General
Category: HIV
12/11/2024 Gilead Sciences, Inc. Biktarvy (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $400.00 General
Category: HIV
12/09/2024 Merck Sharp & Dohme LLC DIFICID (Drug), ZERBAXA Food and Beverage In-kind items and services $13.87 General
Category: INFECTIOUS DISEASE
12/06/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $21.68 General
12/04/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $29.34 General
Category: Respiratory
11/22/2024 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $21.00 General
Category: HIV
11/20/2024 Gilead Sciences, Inc. — Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,980.00 General
11/20/2024 ViiV Healthcare Company DOVATO (Drug) Food and Beverage In-kind items and services $20.29 General
Category: HIV
11/19/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $80.70 General
11/13/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $26.35 General
11/12/2024 ABBVIE INC. AVYCAZ (Drug), DALVANCE, TEFLARO Food and Beverage In-kind items and services $18.00 General
Category: ANTI-INFECTIVE
11/04/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $17.73 General
Category: Respiratory
10/30/2024 Merck Sharp & Dohme LLC PIFELTRO (Drug), DELSTRIGO Food and Beverage In-kind items and services $12.80 General
Category: INFECTIOUS DISEASE
10/28/2024 Merck Sharp & Dohme LLC DIFICID (Drug), ZERBAXA Food and Beverage In-kind items and services $25.61 General
Category: INFECTIOUS DISEASE
10/23/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $21.96 General
10/22/2024 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $25.09 General
10/16/2024 ABBVIE INC. AVYCAZ (Drug), DALVANCE, TEFLARO Food and Beverage In-kind items and services $15.68 General
Category: ANTI-INFECTIVE
10/07/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $22.03 General
Category: Respiratory
09/30/2024 Merck Sharp & Dohme LLC DIFICID (Drug), ZERBAXA Food and Beverage In-kind items and services $22.01 General
Category: INFECTIOUS DISEASE
09/27/2024 ABBVIE INC. DALVANCE (Drug), TEFLARO, AVYCAZ Food and Beverage In-kind items and services $3.21 General
Category: ANTI-INFECTIVE
09/18/2024 Merck Sharp & Dohme LLC PIFELTRO (Drug), DELSTRIGO Food and Beverage In-kind items and services $17.27 General
Category: INFECTIOUS DISEASE
09/17/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $22.40 General
Category: Respiratory
09/13/2024 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $15.48 General
Category: HIV
09/12/2024 ABBVIE INC. TEFLARO (Drug), DALVANCE, AVYCAZ Food and Beverage In-kind items and services $19.34 General
Category: ANTI-INFECTIVE
09/11/2024 Astellas Pharma US Inc Cresemba (Drug) Food and Beverage In-kind items and services $25.32 General
Category: Infectious Diseases
123…22»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 572 980 $142,370 $81,718
2022 7 606 989 $142,893 $83,207
2021 9 681 1,876 $374,885 $127,779
2020 12 881 194,789 $950,924 $190,528
Total Patients
2,740
Total Services
198,634
Medicare Billing
$483,231
Procedure Codes
34

All Medicare Procedures & Services

34 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 205 232 $51,774 $27,884 53.9%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 171 360 $33,288 $20,112 60.4%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 95 201 $33,165 $17,394 52.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 71 152 $19,075 $12,793 67.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 18 21 $3,948 $2,718 68.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 12 14 $1,120 $815.75 72.8%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 211 218 $48,626 $31,140 64.0%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 163 367 $33,703 $18,932 56.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 110 192 $31,680 $14,162 44.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 73 158 $19,775 $13,474 68.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 19 23 $4,324 $2,694 62.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 17 17 $3,665 $1,945 53.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 13 14 $1,120 $860.47 76.8%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 222 236 $52,648 $33,623 63.9%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 175 427 $39,258 $22,668 57.7%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 131 252 $41,580 $19,004 45.7%
96521 Refilling and maintenance of portable pump Office 2021 17 156 $58,500 $15,955 27.3%
96365 Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Office 2021 20 226 $50,850 $11,365 22.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 64 125 $15,725 $10,675 67.9%
J1335 Injection, ertapenem sodium, 500 mg Office 2021 13 408 $110,160 $10,211 9.3%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 18 23 $4,324 $3,079 71.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 21 23 $1,840 $1,200 65.2%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 251 273 $60,579 $40,129 66.2%
96365 Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Office 2020 31 619 $139,275 $30,860 22.2%
J0878 Injection, daptomycin, 1 mg Office 2020 13 190,908 $458,179 $28,929 6.3%
12»

About Dr. Daniel Young, MD

Dr. Daniel Young, MD is a Internal Medicine healthcare provider based in Bentonville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1265656425.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Young, MD has received a total of $41,853 in payments from pharmaceutical and medical device companies, with $20,335 received in 2024. These payments were reported across 549 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($27,440).

As a Medicare-enrolled provider, Young has provided services to 2,740 Medicare beneficiaries, totaling 198,634 services with total Medicare billing of $483,231. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Infectious Disease
  • Location Bentonville, AR
  • Active Since 04/12/2007
  • Last Updated 05/15/2012
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1265656425

Products in Payments

  • Biktarvy (Drug) $27,686
  • Arikayce (Drug) $1,203
  • DOVATO (Drug) $931.26
  • AVYCAZ (Drug) $720.75
  • VIBATIV (Drug) $719.33
  • CABENUVA (Biological) $433.44
  • XERAVA (Drug) $339.92
  • PIFELTRO (Drug) $333.23
  • DIFICID (Drug) $327.16
  • DALVANCE (Drug) $232.43
  • TEFLARO (Drug) $232.25
  • JULUCA (Drug) $227.48
  • MAVYRET (Drug) $175.30
  • ZERBAXA (Drug) $158.71
  • NUZYRA (Drug) $148.25
  • ISENTRESS (Drug) $137.30
  • CRESEMBA (Drug) $120.99
  • Vibativ (Drug) $101.91
  • TRIUMEQ (Drug) $91.35
  • Cresemba (Drug) $90.63

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Bentonville

Dr. Roberto Saez, Md, MD

Internal Medicine — Payments: $11,387

Internal Medicine $11,387

Ms. Brenda Rude, Md, MD

Internal Medicine — Payments: $10,040

Internal Medicine $10,040

Rupali Paradkar, Md, MD

Internal Medicine — Payments: $9,607

Internal Medicine $9,607

Dr. Maria Baldasare, M.d, M.D

Internal Medicine — Payments: $8,287

Internal Medicine $8,287

Dr. Shalini Bichala, Mbbs, MBBS

Internal Medicine — Payments: $4,309

Internal Medicine $4,309

Dr. James Byrum, Md, MD

Internal Medicine — Payments: $4,054

Internal Medicine $4,054